A citation-based method for searching scientific literature

Hsiuying Wang. Int J Mol Sci 2021
Times Cited: 6







List of co-cited articles
35 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
Lijia Chang, Kai Zhang, Yaoyu Pu, Youge Qu, Si-Ming Wang, Zhongwei Xiong, Qian Ren, Chao Dong, Yuko Fujita, Kenji Hashimoto. Pharmacol Biochem Behav 2019
77
33

The second brain: The connection between gut microbiota composition and multiple sclerosis.
Melina Farshbafnadi, Elmira Agah, Nima Rezaei. J Neuroimmunol 2021
7
33

A historical review of antidepressant effects of ketamine and its enantiomers.
Yan Wei, Lijia Chang, Kenji Hashimoto. Pharmacol Biochem Behav 2020
73
33

(R)-Ketamine ameliorates lethal inflammatory responses and multi-organ injury in mice induced by cecum ligation and puncture.
Jiancheng Zhang, Li Ma, Yaeko Hashimoto, Xiayun Wan, Jiajing Shan, Youge Qu, Kenji Hashimoto. Life Sci 2021
11
33

Depression in multiple sclerosis: Is one approach for its management enough?
C Danielle Jones, Robert Motl, Brian M Sandroff. Mult Scler Relat Disord 2021
8
33

An update on ketamine and its two enantiomers as rapid-acting antidepressants.
Kai Zhang, Kenji Hashimoto. Expert Rev Neurother 2019
64
33

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis.
Jacqueline Nicholas, Huanxue Zhou, Chinmay Deshpande. Adv Ther 2021
5
40


Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling.
Youge Qu, Jiajing Shan, Siming Wang, Lijia Chang, Yaoyu Pu, Xingming Wang, Yunfei Tan, Masayuki Yamamoto, Kenji Hashimoto. Eur Arch Psychiatry Clin Neurosci 2021
18
33


Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
142
33


Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.
Jordi Bonaventura, Sherry Lam, Meghan Carlton, Matthew A Boehm, Juan L Gomez, Oscar Solís, Marta Sánchez-Soto, Patrick J Morris, Ida Fredriksson, Craig J Thomas,[...]. Mol Psychiatry 2021
58
33


(R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation.
Jiancheng Zhang, Li Ma, Xiayun Wan, Jiajing Shan, Youge Qu, Kenji Hashimoto. Psychopharmacology (Berl) 2021
19
33

Ketamine: A tale of two enantiomers.
Luke A Jelen, Allan H Young, James M Stone. J Psychopharmacol 2021
49
33

Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine.
Kai Zhang, Akemi Sakamoto, Lijia Chang, Youge Qu, Siming Wang, Yaoyu Pu, Yunfei Tan, Xingming Wang, Yuko Fujita, Tamaki Ishima,[...]. Eur Arch Psychiatry Clin Neurosci 2021
25
33


Depression in multiple sclerosis: a review.
R J Siegert, D A Abernethy. J Neurol Neurosurg Psychiatry 2005
423
33

Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.
Chun Yang, Youge Qu, Yuko Fujita, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Transl Psychiatry 2017
122
33


Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Gustavo C Leal, Igor D Bandeira, Fernanda S Correia-Melo, Manuela Telles, Rodrigo P Mello, Flavia Vieira, Cassio S Lima, Ana Paula Jesus-Nunes, Lívia N F Guerreiro-Costa, Roberta F Marback,[...]. Eur Arch Psychiatry Clin Neurosci 2021
103
33



Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
Jalal Dahham, Rana Rizk, Ingrid Kremer, Silvia M A A Evers, Mickaël Hiligsmann. Pharmacoeconomics 2021
13
33

Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.
Chun Yang, Qian Ren, Youge Qu, Ji-Chun Zhang, Min Ma, Chao Dong, Kenji Hashimoto. Biol Psychiatry 2018
138
33

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
336
33

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
873
33


Targeting the gut to treat multiple sclerosis.
Laura Ghezzi, Claudia Cantoni, Gabriela V Pinget, Yanjiao Zhou, Laura Piccio. J Clin Invest 2021
13
33

Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.
Kenji Hashimoto, Takeharu Kakiuchi, Hiroyuki Ohba, Shingo Nishiyama, Hideo Tsukada. Eur Arch Psychiatry Clin Neurosci 2017
83
33


Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.
Jaskaran B Singh, Maggie Fedgchin, Ella Daly, Liwen Xi, Caroline Melman, Geert De Bruecker, Andre Tadic, Pascal Sienaert, Frank Wiegand, Husseini Manji,[...]. Biol Psychiatry 2016
225
33

Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis.
Ivana Bjelobaba, Vesna Begovic-Kupresanin, Sanja Pekovic, Irena Lavrnja. J Neurosci Res 2018
81
33

Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling.
Yuko Fujita, Yaeko Hashimoto, Hiroyo Hashimoto, Lijia Chang, Kenji Hashimoto. Eur J Pharmacol 2021
8
33

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Cris S Constantinescu, Nasr Farooqi, Kate O'Brien, Bruno Gran. Br J Pharmacol 2011
779
16

Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Xu Wang, Zhen Liang, Shengnan Wang, Di Ma, Mingqin Zhu, Jiachun Feng. Curr Neuropharmacol 2022
4
25

The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
Fengna Chu, Mingchao Shi, Chao Zheng, Donghui Shen, Jie Zhu, Xiangyu Zheng, Li Cui. J Neuroimmunol 2018
149
16

Depression in multiple sclerosis.
S B Patten, L M Metz. Psychother Psychosom 1997
73
16

Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Matthew J Craner, Tina G Damarjian, Shujun Liu, Bryan C Hains, Albert C Lo, Joel A Black, Jia Newcombe, M Louise Cuzner, Stephen G Waxman. Glia 2005
188
16



Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population.
Yao-Ching Huang, Wu-Chien Chien, Chi-Hsiang Chung, Hsin-An Chang, Yu-Chen Kao, Fang-Jung Wan, Shi-Hao Huang, Ren-Jei Chung, Richard S Wang, Bing-Long Wang,[...]. Neuropsychiatr Dis Treat 2021
1
100

Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders.
Jeffrey J Lochhead, Junzhi Yang, Patrick T Ronaldson, Thomas P Davis. Front Physiol 2020
92
16

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.
Andrew P Robinson, Christopher T Harp, Avertano Noronha, Stephen D Miller. Handb Clin Neurol 2014
254
16


Claudin-5: gatekeeper of neurological function.
Chris Greene, Nicole Hanley, Matthew Campbell. Fluids Barriers CNS 2019
163
16

TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice.
Diulle Spat Peres, Maria Carolina Theisen, Maria Fernanda Pessano Fialho, Diéssica Padilha Dalenogare, Patrícia Rodrigues, Sabrina Qader Kudsi, Laura de Barros Bernardes, Náthaly Andrighetto Ruviaro da Silva, Débora Denardin Lückemeyer, Tuane Bazanella Sampaio,[...]. Brain Res Bull 2021
7
16


Role of microglia in multiple sclerosis.
Xinqing Deng, Subramaniam Sriram. Curr Neurol Neurosci Rep 2005
15
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.